TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation

Circulating cell-free DNA (cfDNA) is emerging as a potential tumor biomarker. CfDNA-based biomarkers may be applicable in tumors without an available non-invasive screening method among at-risk populations. Esophageal squamous cell carcinoma (ESCC) and residents of the Asian cancer belt are examples...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasrollahzadeh, Dariush, Roshandel, Gholamreza, Delhomme, Tiffany Myriam, Avogbe, Patrice Hodonou, Foll, Matthieu, Saidi, Farrokh, Poustchi, Hossein, Sotoudeh, Masoud, Malekzadeh, Reza, Brennan, Paul, Mckay, James, Hainaut, Pierre, Abedi-Ardekani, Behnoush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197963/
https://www.ncbi.nlm.nih.gov/pubmed/34073316
http://dx.doi.org/10.3390/ijms22115627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197963/
https://www.ncbi.nlm.nih.gov/pubmed/34073316
http://dx.doi.org/10.3390/ijms22115627

Ejemplares similares